Back to press releases
  • Group
  • Press release

CIB for Health and Medical Research 2014

Six years on, BNP Paribas Corporate & Investment Banking, has been sponsoring the Institut Pasteur, supporting medical research in thirteen countries in 2014.

BNP Paribas CIB offers financial aid to two teams from the Institut Pasteur in Paris, and to several teams from the International Network of Institut Pasteur abroad as well as to laboratories working in collaboration with French “Pasteurian” scientists.

Research projects are often linked to public health problems encountered in each of the thirteen countries of the program. They include the development of a combined vaccine against measles and AIDS in France and United Kingdom for example, research on various diseases such as hepatitis (Spain, Belgium or Russia), malaria (Brazil), dengue fever (Hong-Kong), diphtheria (Poland), or leshmaniasis (Canada)…


In 2013, scientific programs supported by CIB in different countries led to major results, among them :

-> a vaccination protocol that completely protects immunized mice against experimental malaria (Brazil)

-> the efficacy in animal models of combined measles vaccines against arboviruses transmitted by mosquitoes (dengue, chikungunya, west Nile diseases) has been demonstrated (Institut Pasteur in Paris)

-> a novel host factor implied in dengue virus internal capture was discovered, which could been crucial for the development of effective therapeutics strategies (Hong Kong University Pasteur Research Center).

The diagnosis of French case of the new Middle East Respiratory Syndrome coronavirus as well as studies about virus genomics and heat inactivation of this virus (Institut Pasteur in Paris).

To date, BNP Paribas is an important partner of the Pasteur Institute. Since 2008, the financial support brought by BNP Paribas Corporate & Investment Banking represents nearly 2.3 million Euros.

About BNP Paribas Corporate and Investment Banking
BNP Paribas Corporate and Investment Banking (CIB) is a leading provider of solutions to a wide range of clients including corporates, sovereigns, financial institutions and investors worldwide. Approximately 19,000 professionals in 45 countries provide clients with personalized services for managing their risks and assets, financing and expanding their business and servicing their operational needs.

BNP Paribas CIB excels in:
Corporate Banking - where it has leading franchises in Transaction Banking (trade finance, cash management) and in Specialized Financing (energy & commodities, transportation, export, project, leveraged, media telecom, corporate acquisition finance and real estate)
Derivatives - where it is one of the leading global players in interest rates, credit, foreign exchange, commodity and equity derivatives.
Advisory and Capital Markets - where it is a top European house in ECM and a global leader in DCM (bond, convertibles and equity issuance)

About Institut Pasteur
Louis Pasteur created the Institut Pasteur in 1887 as a private non-profit foundation that rapidly became worldrenowned for its biomedical research. The main aim of the Institut Pasteur is understanding and preventing diseases throughout the world through excellent scientific and public health research, teaching and other activities. Together with its major contribution to a deeper understanding of fundamental aspects of life, the Institut Pasteur continues to devote a large part of its efforts to infectious diseases, inherited disorders, neurodegenerative diseases and certain cancers. Close to 2,600 people work on its main campus in Paris, which is at the heart of an international network of 32 research institutes on 5 continents. Over the years, 10 Institut Pasteur researchers have received the Nobel Prize.